Us Congress 2025-2026 Regular Session

Us Congress House Bill HB526

Introduced
1/16/25  

Caption

Declaration of Energy Independence Act

Impact

The bill is likely to have significant implications for state laws governing energy extraction and revenue generation from federal lands. By lowering the royalty rates, the Act aims to stimulate economic growth within the oil and gas sectors, potentially leading to increased job creation and investment in energy infrastructure. Proponents argue that such measures will enhance national energy independence and competitiveness in the global market. However, the alteration of royalty rates can lead to decreased revenue for federal and state governments that rely on these funds for public services.

Summary

House Bill 526, known as the Declaration of Energy Independence Act, proposes amendments to the Mineral Leasing Act regarding royalties associated with oil and gas extraction on federal land. The main thrust of the bill is to reduce the royalty rate from 16.67% to 12.5% for leasing oil and gas land on federal properties. Additionally, it seeks to modify conditions and requirements for reinstating leases, which may significantly affect how oil and gas companies operate on these lands. The reductions in royalty rates are expected to encourage deeper exploration and more competitive bidding in leasing processes.

Contention

However, the bill has sparked debates regarding the long-term environmental impacts associated with increased drilling activities on federal lands. Critics argue that by lowering costs for oil and gas extraction, the bill could motivate over-exploitation of resources, which may contribute to environmental degradation and fuel climate change. They express concerns that prioritizing energy independence through this bill neglects the need for sustainable practices and may undermine federal efforts to reduce carbon emissions.

Congress_id

119-HR-526

Policy_area

Energy

Introduced_date

2025-01-16

Companion Bills

No companion bills found.

Similar Bills

US SB331

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the bill establishes a new, alternative registration process for certain schedule I research.The bill also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

US HB2031

HOME Investment Partnerships Reauthorization and Improvement Act of 2025

US SB263

FAIR Act of 2025 Fifth Amendment Integrity Restoration Act of 2025

US SB93

Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025

US HB644

Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025

US SB445

Carried Interest Fairness Act of 2025

US HB27

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the bill establishes a new, alternative registration process for certain schedule I research.The bill also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

US HB1048

Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act or the DETERRENT ActThis bill expands oversight and disclosure requirements related to foreign sources and institutions of higher education (IHEs).Specifically, the bill requires an IHE to annually disclose to the Department of Education (ED) any year in which the IHEreceives a gift from a foreign country of concern (e.g., China or Russia) or foreign entity of concern of any dollar amount;receives a gift or contract from a foreign source (other than a foreign country of concern or foreign entity of concern) that is valued at $50,000 or more, considered alone or in combination with all other gifts or contracts within a calendar year (current disclosure threshold is $250,000 or more), or which has an undetermined monetary value;enters into a contract with a foreign country of concern or foreign entity of concern after receiving a waiver for such contract; oris substantially controlled by a foreign source.Additionally, the billprohibits IHEs from entering into contracts with a foreign country of concern or with a foreign entity of concern without obtaining a waiver,requires certain IHEs to disclose gifts or contracts between covered individuals (e.g., researchers) and foreign sources, andrequires private IHEs with specified assets or investments to file annual investment disclosure reports.The bill requires ED to investigate possible violations of this bill and outlines the various penalties for each violation. Penalties may include losing eligibility for federal student financial aid.